Complex management of GS (Good’s syndrome) with persistent COVID-19 infection and polymicrobial infections: A case report.

Complex management of GS (Good’s syndrome) with persistent COVID-19 infection and polymicrobial infections: A case report.

Publication date: Jan 15, 2025

This case report highlights the diagnostic and therapeutic complexities faced by a 56-year-old female with Good’s syndrome (GS), who presented with persistent Coronavirus Disease 2019 (COVID-19) infection alongside Aspergillus spp, cytomegalovirus, and Pseudomonas aeruginosa co-infection, which collectively contributed to severe pulmonary involvement. The report further emphasizes a multifaceted treatment approach, incorporating antivirals, antifungals, antimicrobials, immunoglobulins, and antifibrotic therapy, which ultimately led to an improvement in the patient’s condition. It underscored the intricate challenges of managing immunocompromised patients with multiple concurrent infections. The detailed diagnosis and treatment process of this complex case provides valuable insights to clinicians managing similar scenarios.

Concepts Keywords
Antivirals Case report
Clinicians COVID-19
Cytomegalovirus Good’s syndrome
Old Polymicrobial infections
Pulmonary

Semantics

Type Source Name
disease MESH syndrome
disease MESH COVID-19
disease MESH infection
disease MESH polymicrobial infections
disease MESH immunocompromised patients
disease IDO process

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *